227 related articles for article (PubMed ID: 15518544)
1. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
Mitra A; Sept D
Biochemistry; 2004 Nov; 43(44):13955-62. PubMed ID: 15518544
[TBL] [Abstract][Full Text] [Related]
2. Two photoaffinity analogues of the tripeptide, hemiasterlin, exclusively label alpha-tubulin.
Nunes M; Kaplan J; Wooters J; Hari M; Minnick AA; May MK; Shi C; Musto S; Beyer C; Krishnamurthy G; Qiu Y; Loganzo F; Ayral-Kaloustian S; Zask A; Greenberger LM
Biochemistry; 2005 May; 44(18):6844-57. PubMed ID: 15865430
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction.
Bai R; Schwartz RE; Kepler JA; Pettit GR; Hamel E
Cancer Res; 1996 Oct; 56(19):4398-406. PubMed ID: 8813133
[TBL] [Abstract][Full Text] [Related]
4. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1.
Bai R; Durso NA; Sackett DL; Hamel E
Biochemistry; 1999 Oct; 38(43):14302-10. PubMed ID: 10572005
[TBL] [Abstract][Full Text] [Related]
5. Natural organic compounds that affect to microtubule functions.
Iwasaki S
Yakugaku Zasshi; 1998 Apr; 118(4):112-26. PubMed ID: 9564789
[TBL] [Abstract][Full Text] [Related]
6. Stability of drug-induced tubulin rings by fluorescence correlation spectroscopy.
Boukari H; Nossal R; Sackett DL
Biochemistry; 2003 Feb; 42(5):1292-300. PubMed ID: 12564932
[TBL] [Abstract][Full Text] [Related]
7. Interactions of antimitotic peptides and depsipeptides with tubulin.
Hamel E
Biopolymers; 2002; 66(3):142-60. PubMed ID: 12385035
[TBL] [Abstract][Full Text] [Related]
8. Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions.
Bai R; Taylor GF; Schmidt JM; Williams MD; Kepler JA; Pettit GR; Hamel E
Mol Pharmacol; 1995 May; 47(5):965-76. PubMed ID: 7746283
[TBL] [Abstract][Full Text] [Related]
9. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
[TBL] [Abstract][Full Text] [Related]
10. The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies.
Magnani M; Ortuso F; Soro S; Alcaro S; Tramontano A; Botta M
FEBS J; 2006 Jul; 273(14):3301-10. PubMed ID: 16803461
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
[TBL] [Abstract][Full Text] [Related]
12. Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography.
Cruz-Monserrate Z; Mullaney JT; Harran PG; Pettit GR; Hamel E
Eur J Biochem; 2003 Sep; 270(18):3822-8. PubMed ID: 12950266
[TBL] [Abstract][Full Text] [Related]
13. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.
Bai R; Friedman SJ; Pettit GR; Hamel E
Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820
[TBL] [Abstract][Full Text] [Related]
14. Structure-based identification of the binding site for the hemiasterlin analogue HTI-286 on tubulin.
Ravi M; Zask A; Rush TS
Biochemistry; 2005 Dec; 44(48):15871-9. PubMed ID: 16313189
[TBL] [Abstract][Full Text] [Related]
15. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.
Bai RL; Pettit GR; Hamel E
J Biol Chem; 1990 Oct; 265(28):17141-9. PubMed ID: 2211617
[TBL] [Abstract][Full Text] [Related]
16. Direct photoaffinity labeling by dolastatin 10 of the amino-terminal peptide of beta-tubulin containing cysteine 12.
Bai R; Covell DG; Taylor GF; Kepler JA; Copeland TD; Nguyen NY; Pettit GR; Hamel E
J Biol Chem; 2004 Jul; 279(29):30731-40. PubMed ID: 15123603
[TBL] [Abstract][Full Text] [Related]
17. The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain.
Bai R; Taylor GF; Cichacz ZA; Herald CL; Kepler JA; Pettit GR; Hamel E
Biochemistry; 1995 Aug; 34(30):9714-21. PubMed ID: 7626642
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the antitumor compound cryptophycin-52 with tubulin.
Panda D; Ananthnarayan V; Larson G; Shih C; Jordan MA; Wilson L
Biochemistry; 2000 Nov; 39(46):14121-7. PubMed ID: 11087360
[TBL] [Abstract][Full Text] [Related]
19. Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding.
Li Y; Kobayashi H; Hashimoto Y; Shirai R; Hirata A; Hayashi K; Hamada Y; Shioiri T; Iwasaki S
Chem Biol Interact; 1994 Dec; 93(3):175-83. PubMed ID: 7923438
[TBL] [Abstract][Full Text] [Related]
20. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.
Bai R; Pettit GR; Hamel E
Biochem Pharmacol; 1990 Jun; 39(12):1941-9. PubMed ID: 2353935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]